Drugs / Bone marrow mesenchimal stem cells
Bone marrow mesenchimal stem cells
Trials 0
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02365142 Comparator | Jun 2014 → Jun 2018 | osteoarthritis, knee | Clinica Universidad de Navarra, Universidad de Navarra | Unknown | No outcome recorded |
| Phase 1/2 | NCT02123368 Comparator | May 2012 → Nov 2014 | osteoarthritis | Clinica Universidad de Navarra, Universidad de Navarra | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bone marrow mesenchimal stem cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02123368 ↗ |
| Known as | BM-MSCs | “A phase I/II multicenter randomized clinical trial with active control was conducted between 2012 and 2014. Thirty patients diagnosed with knee OA were randomly assigned to...” PMID 30064455 ↗ Jul 20181“Here, we evaluated the clinical effects of a dose of 100 × 106 bone marrow mesenchymal stromal cells (BM-MSCs) in combination with Platelet Rich Plasma (PRGF®) as adjuvant in a...” PMID 32948200 ↗ Sep 2020 |
| Known as | mesenchymal stem cells | “Purpose: To determine the safety, feasibility and effectiveness (clinical and radiological) of intra-articular administration of autologous mesenchymal stem cells (MSCs) in...” NCT02123368 ↗ |
| Modality | Cell therapy | “cultured autologous bone marrow-derived MSCs” PMID 30064455 ↗ Jul 2018 |
| Route | Other | “Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid” PMID 30064455 ↗ Jul 2018 |